نتائج البحث

Durvalumab With or Without Tremelimumab in Combination With Chemotherapy in First-Line Metastatic NSCLC: Five-Year Overall Survival Outcomes From the Phase 3 POSEIDON Trial.

• Authors : Peters, S.; Cho, B.C.; Luft, A.V.

Subjects: Humans; Carcinoma; Non-Small-Cell Lung/drug therapy

• Source: Journal of thoracic oncology, vol. 20, no. 1, pp. 76-93

تفاصيل العنوان

Crossover in Adjuvant Trastuzumab Trials: Sparing Toxicity in Patient Care.

• Authors : Tuia, Jordan; Olivier, Timothée; Prasad, Vinay K

Subjects: Antibodies; Monoclonal; Humanized: therapeutic use

• Source: American journal of clinical oncology. 45(10)

تفاصيل العنوان

Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages

• Authors : Driouich, Jean-Sélim; Cochin, Maxime; Lingas, Guillaume ...

Subjects: AZD7442; Clinical therapeutics; Monoclonal antibody

• Source: ISSN: 0753-3322.

تفاصيل العنوان

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

• Authors : Leleu, Xavier; Hulin, Cyrille; Lambert, Jerome ...

Subjects: MESH: Aged; MESH: Antibodies; Monoclonal

• Source: ISSN: 1078-8956.

تفاصيل العنوان

Quantitative assessment of baseline imbalances in evolocumab and alirocumab trials:a meta-epidemiological study

• Authors : van Bruggen, F H; Zuidema, S U; Luijendijk, H J

Subjects: Humans; Antibodies; Monoclonal

• Source: van Bruggen , F H , Zuidema , S U & Luijendijk , H J 2024 , ' Quantitative assessment of baseline imbalances in evolocumab and alirocumab trials : a meta-epidemiological study ' , BMC Medical Research

تفاصيل العنوان

Limited predictive value of the gut microbiome and metabolome for response to biological therapy in inflammatory bowel disease

• Authors : Prins, Femke M; Hidding, Iwan J; Klaassen, Marjolein A Y ...

Subjects: Adult; Antibodies; Monoclonal

تفاصيل العنوان

Design of a phase 3, randomized, double-blind, placebo-controlled, 48-week study to evaluate the efficacy and safety of cendakimab in adult and adolescent patients with eosinophilic esophagitis.

• Authors : Charriez, C.M.; Zhang, S.; de Oliveira, CHMC

Subjects: Humans; Eosinophilic Esophagitis/drug therapy; Double-Blind Method

• Source: Contemporary clinical trials, vol. 147, pp. 107708

تفاصيل العنوان

Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis

Subjects: Humans; Antibodies; Monoclonal

• Source: 2024 , ' Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis ' , Rheumatology , vol. 63 , no. 9 , pp. 2535-2546 .

تفاصيل العنوان

Clinical Outcomes of Older and Younger Patients Treated with Loncastuximab Tesirine in the LOTIS-2 Clinical Trial

• Authors : Hamadani, Mehdi; Spira, Alexander I; Zhou, Xiaolei

Subjects: Antibodies; Monoclonal; Humanized/therapeutic use

• Source: Hamadani , M , Spira , A I , Zhou , X , Liao , L , Chen , L , Radford , J , Ai , W Z , Solh , M M , Ardeshna , K M , Hess , B T , Caimi , P F , Stathis , A , Carlo Stella , C , Alderuccio , J P , Kahl

تفاصيل العنوان

Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non-small cell lung cancer, and renal cell carcinoma.

• Authors : Luke, J.J.; Long, G.V.; Robert, C.

Subjects: Humans; Antibodies; Monoclonal

• Source: European journal of cancer, vol. 207, pp. 114146

تفاصيل العنوان